Enanta Pharmaceuticals
ENTA
#7520
Rank
HK$3.17 B
Marketcap
HK$109.85
Share price
-0.21%
Change (1 day)
101.85%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: HK$3.17 Billion

As of December 2025 Enanta Pharmaceuticals has a market cap of HK$3.17 Billion. This makes Enanta Pharmaceuticals the world's 7520th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$3.17 B220.62%
2024HK$0.98 B-36.1%
2023HK$1.54 B-79.53%
2022HK$7.55 B-36.78%
2021HK$11.95 B82.46%
2020HK$6.55 B-31.25%
2019HK$9.53 B-11.58%
2018HK$10.77 B22.94%
2017HK$8.76 B77.28%
2016HK$4.94 B2.83%
2015HK$4.81 B-34.48%
2014HK$7.34 B93.17%
2013HK$3.80 B

End of Day market cap according to different sources

On Dec 11th, 2025 the market cap of Enanta Pharmaceuticals was reported to be:

HK$3.17 Billion
by Nasdaq info icon info icon
HK$3.17 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AbbVie
ABBV
HK$3.056 T 96,295.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$3.947 T 124,416.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$892.64 B 28,053.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$1.927 T 60,680.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$834.06 B 26,206.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$1.980 T 62,356.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland